• Username (E-mail)
  • Password
Dow 20,760 -0.2%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0568 -0.1% 
Nasdaq 5,825 -0.2%  FTSE100 7,244 -0.4%  Yen 112.1080 -0.5%  Oil 56.0 -0.8% 
S&P500 2,359 -0.2%  DAX 11,804 -1.2%  GBP 1.2462 -0.7%  Gold 1,257 0.6% 

Biomarin Pharmaceutical share [Symbol: BMRN / ISIN: US09061G1013]

Realtimequote Biomarin Pharmaceutical Inc. in USD

Exchange Market
86.54
Last
57,287
Volume
Time 02:21 PM
02/24/2017 02:21:58 PM UTC-0500
activate push

Stock Price Biomarin Pharmaceutical Inc. in USD

Activate push
86.62 USD -2.67 USD -2.99 %
Trade Time 2:08 PM Trade Date 2/24/2017
Daily High 88.80 Open 87.99
Daily Low 85.95 Prev. Close 89.29
52-week High 102.43 Volume (Qty.) 570,425
52-week Low 73.60 Market Cap (USD) 15.55 B
52-week Perf.
Exchange

Analyst Opinions for Biomarin Pharmaceutical Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
11/06/12
Biomarin Pharmaceutical RBC Capital Markets
09/03/12
Biomarin Pharmaceutical RBC Capital Markets
08/28/12
Biomarin Pharmaceutical Deutsche Bank Securities
07/23/12
Biomarin Pharmaceutical RBC Capital Markets
06/22/12
Biomarin Pharmaceutical RBC Capital Markets

Moody's Rating for Biomarin Pharmaceutical Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Biomarin Pharmaceutical Inc.

Company Profile
BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions. Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM. The company was founded on March 21, 1997 and is headquartered in Novato, CA.
pagehit

Add or Edit Instrument

Biomarin Pharmaceutical Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Biomarin Pharmaceutical

2015 2016e 2017e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio -96.60 -24.27 -81.21
EPS -1.07 -3.70 -1.11

Biomarin Pharmaceutical Key Figures

Market Cap (USD) 15.55 B
Free Float in % 99.42
Number of Shares (Mio.) 171.99
Cash Flow per Share -1.96
Book Value per Share 8.30
60-Days Volatility 35.66
P/B Ratio 12.45

Base Data Biomarin Pharmaceutical

Symbol BMRN
ISIN US09061G1013
Indices NASDAQ Comp., NASDAQ 100

About the Company Biomarin Pharmaceutical

Country USA

Biomarin Pharmaceutical Historical Prices

02/22/2017
02/22/2017 06:00:00 PM UTC-0500
89.29 437,451
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
89.79 368,299
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
90.24 487,196
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
89.87 450,234
02/15/2017
02/15/2017 06:00:00 PM UTC-0500
90.53 700,901

Biomarin Pharmaceutical Peer Group

Similar shares with higher 1-year perf.